...
首页> 外文期刊>Drug development and industrial pharmacy >Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
【24h】

Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.

机译:Eudragit NE40-药物混合包衣系统,用于控制核心药丸的药物释放。

获取原文
获取原文并翻译 | 示例

摘要

This study was aimed at developing a controlled-release coating system around core pellets with aqueous dispersion, along with some water channeling agents. Core pellets of diltiazem were prepared using the extrusion-spheronization technique and subsequently coated with aqueous dispersion of Eudragit NE40 alone, or drug-polymer mixtures using bottom-spray fluidized bed coater. The lag time in drug release profiles increased as the coating levels of Eudragit NE40 were increased, whereas no lag time was observed in core pellets coated with drug-polymer mixtures. Mixed coating at the 7% level exhibited comparatively better release profiles and provided desirable release rates during the 12-hour testing interval. Diltiazem HCl release from mixed coating was fairly independent of pH and drug loading. Curing of coated pellets was found to be an essential step for stable drug release profiles. The selection of core size range had remarkable effect on drug release rate and was considerably reduced by using greater core size.
机译:这项研究的目的是围绕具有水分散体的核心药丸以及一些水通道剂开发一种控释包衣系统。地尔硫卓的芯药丸是使用挤出滚圆技术制备的,随后分别用Eudragit NE40的水分散体或使用底部喷雾流化床包衣机的药物-聚合物混合物进行包衣。随着Eudragit NE40包衣水平的增加,药物释放曲线中的滞后时间增加,而在涂有药物-聚合物混合物的核心药丸中未观察到滞后时间。 7%含量的混合涂料在12小时的测试间隔内显示出相对较好的释放曲线,并提供了理想的释放速率。从混合包衣中释放出盐酸地尔硫卓与pH值和载药量完全无关。发现包衣的小丸的固化是稳定药物释放曲线的重要步骤。核心尺寸范围的选择对药物释放速率有显着影响,并且通过使用更大的核心尺寸可大大减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号